Related Experiment Video
Updated: Apr 14, 2026
09:12
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
6.9K
Realm of hepatitis E: Challenges and opportunities
Jia-Rui Li1, Ze Xiang1, Shu-Hui Li1
1School of Medicine, Zhejiang University, Hangzhou 310058, Zhejiang Province, China.
World Journal of Experimental Medicine
|July 1, 2024
Summary
Hepatitis E virus (HEV) infection is a global health concern, often underdiagnosed in immunocompromised individuals. Research is crucial for better diagnostics, safer treatments, and understanding HEV
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis E virus (HEV) causes significant global morbidity and mortality, particularly in Asia.
- HEV transmission occurs via contaminated water and undercooked meat, leading to underdiagnosis, especially in immunocompromised populations.
- Existing treatments for HEV have limitations and adverse effects, highlighting the need for safer alternatives.
Discussion:
- Extrahepatic manifestations of HEV, affecting neurological and renal systems, require further investigation.
- The study emphasizes the need for improved diagnostic tools for HEV detection.
- Addressing HEV necessitates a multi-pronged approach including research, diagnostics, and public health initiatives.
Key Insights:
- HEV poses a substantial global health challenge with a high infection and mortality rate.
- Underdiagnosis of HEV is prevalent, particularly in immunocompromised patients.
- Safer and more effective treatments for HEV are urgently needed.
Outlook:
- Future research should focus on understanding HEV's extrahepatic effects and developing novel therapies.
- Enhanced public health awareness and preventive measures are critical for controlling HEV.
- Advancements in diagnostics and treatment are essential for managing the global HEV burden.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
01:28Esophageal Varices-II: Clinical Features and Management
811
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
811
01:29Chronic Pancreatitis II: Collaborative Care
521
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
521
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
353
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
353
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
263
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
01:25Hepatitis
59
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
59